parasite histone protein inhibitors (SEtTReND/Kancera/iNovacia)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameparasite histone protein inhibitors (SEtTReND/Kancera/iNovacia)
Drug Alias Nameepigenetic histone protein inhibitors (SEtTReND/Kancera)epigenetic histone protein inhibitors (SEtTReND/Kancera/iNovacia)parasite histone protein inhibitors (SEtTReND/Kancera)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone inhibitorsHistone deacetylase 8 inhibitors
TargetsHistone deacetylase 8Histone
Therapy Area/IndicationsMalariaSchistosomiasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEuropeSwedenFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSEtTReND
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesiNovacia ABSEtTReNDKancera AB
Active IndicationsN/A
Inactive IndicationsMalariaSchistosomiasis

Other Information

ATC CodeN/A
Related LinksN/A